SCHEMBL6669441

SCHEMBL6669441

CCc1ccc(Sc2ccc(C(=O)O)o2)cc1

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.51
NPC1 O15118 2/20 0.51
RAB9A P51151 2/20 0.51
ALDH1A1 P00352 2/20 0.47
TDP1 Q9NUW8 3/20 0.44
LMNA P02545 1/20 0.44
TP53 P04637 1/20 0.44
RXFP1 Q9HBX9 1/20 0.44
POLB P06746 3/20 0.41
PKM P14618 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.41
MAPK1 P28482 1/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
PTPN11 Q06124 1/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11406307 0.85 ALDH1A1 (0.48) KMT2AALDH1A1TDP1POLBPKM
SCHEMBL2110236 0.82 ALDH1A1 (0.46) KMT2AALDH1A1TDP1POLBPKM
SCHEMBL11397187 0.81 NR4A1 (0.44) KMT2AALDH1A1TDP1LMNAPOLB
SCHEMBL7824192 0.81 PTPN11 (0.53) NPC1RAB9AALDH1A1TDP1POLB
SCHEMBL11401902 0.81 KMT2A (0.50) KMT2ANPC1RAB9AALDH1A1TDP1
SCHEMBL6638712 0.81 NPC1 (0.52) NPC1RAB9ATDP1LMNATP53
SCHEMBL25257442 0.80 TDP1 (0.54) KMT2AALDH1A1TDP1POLBL3MBTL1
SCHEMBL11400094 0.77 SMN1; SMN2 (0.50) KMT2ANPC1RAB9AALDH1A1TDP1
SCHEMBL24462053 0.75 TDP1 (0.50) KMT2ANPC1RAB9AALDH1A1TDP1
SCHEMBL6641615 0.74 ALDH1A1 (0.48) NPC1RAB9AALDH1A1TDP1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1401427-A4 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMA (US) 2004-12-01 EP disclosed
EP-1401427-A2 NON-PEPTIDE GNRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM Agouron Pharmaceuticals, Inc. (US) 2004-03-31 EP disclosed
WO-2002098363-A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM AGOURON PHARMACEUTICALS, INC. (US) 2002-12-12 WO disclosed